Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMC

Obesity-associated epigenetic alterations and the obesity-breast cancer axis

Lagarde CB., Kavalakatt J., Benz MC., Hawes ML., Arbogast CA., Cullen NM.

Narrative Review on Hip, published in Oncogene (2024) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Oncogene (2024)
Reported sample size
—
Source database
Europe PMC
PMID
38310162
PMCID
PMC13126611
DOI
10.1038/s41388-024-02954-0
Citations
13

Abstract (original English)

Both breast cancer and obesity can regulate epigenetic changes or be regulated by epigenetic changes. Due to the well-established link between obesity and an increased risk of developing breast cancer, understanding how obesity-mediated epigenetic changes affect breast cancer pathogenesis is critical. Researchers have described how obesity and breast cancer modulate the epigenome individually and synergistically. In this review, the epigenetic alterations that occur in obesity, including DNA methylation, histone, and chromatin modification, accelerated epigenetic age, carcinogenesis, metastasis, and tumor microenvironment modulation, are discussed. Delineating the relationship between obesity and epigenetic regulation is vital to furthering our understanding of breast cancer pathogenesis.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansBreast NeoplasmsObesityHistonesDNA MethylationEpigenesis, GeneticFemaleTumor Microenvironment

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research